Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04687917 · ClinicalTrials.gov registry record · NA
The Substance Abuse Treatment to HIV Care II (SAT2HIV-II) Project
A NA study of Substance Use, sponsored by Ohio State University.
- Active
- Registry status
- NA
- Development phase
- 428
- Enrollment target
- 1
- Study location
NCT04687917: Active NA study of Substance Use, sponsored by Ohio State University.
NCT04687917 is a NA study of Substance Use that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 428 participants, below the 1,256-participant average among 88 other Substance Use trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04687917, a NA study of Substance Use, is active but no longer recruiting, sponsored by Ohio State University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 428 participants
- Enrollment target
- 1
- Study location
Study Summary
An experiment to test the effectiveness of providing monetary bonuses to staff for achieving pre-defined performance targets regarding the implementation of a motivational interviewing-based brief intervention for substance use.
Primary Outcome
The cumulative number of brief interventions that each HSO staff participant implemented with HSO client participants during the implementation phase.
Conditions Studied
Interventions
- BEHAVIORAL The facilitation, training, feedback, and consultation (FTFC) Strategy
- BEHAVIORAL The facilitation, training, feedback, consultation, and incentivization (FTFCI) Strategy
Study Locations (1)
Ohio
- The Ohio State University - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 428 participants |
| Start Date | 2021-01-14 |
| Est. Completion | 2026-05-31 |
| Phase | NA |
What the registry record for NCT04687917 still lists
NCT04687917 is an interventional study that assigns participants to a tested intervention. The registered 428 participants enrollment target is mid-sized for trials with a published cap, below the 1,256-participant average among 88 other Substance Use trials with a reported enrollment target (66% lower).
The record links to 1 condition, with Substance Use appearing as the primary indexed condition, and to 2 interventions - of which The facilitation, training, feedback, and consultation (FTFC) Strategy is the first listed.
NCT04687917 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT04687917 about?
NCT04687917 is a clinical study titled "The Substance Abuse Treatment to HIV Care II (SAT2HIV-II) Project". An experiment to test the effectiveness of providing monetary bonuses to staff for achieving pre-defined performance targets regarding the implementation of a motivational interviewing-based brief intervention for substance use.
What is the current status of trial NCT04687917?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 428 participants. The study started on 2021-01-14. Estimated completion is 2026-05-31.
What conditions does trial NCT04687917 study?
This clinical trial studies the following conditions: Substance Use.
What interventions are being tested in trial NCT04687917?
The interventions under investigation include: The facilitation, training, feedback, and consultation (FTFC) Strategy (BEHAVIORAL), The facilitation, training, feedback, consultation, and incentivization (FTFCI) Strategy (BEHAVIORAL).
Who is sponsoring clinical trial NCT04687917?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04687917 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Substance Use
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04687917's enrollment target sits among peer trials
428 23rd of 88 higher than 66 of 88 other Substance Use trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Substance Use trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Native Spirit: Significant Aim 3: Intervention
RECRUITING · NA
-
Parent SMART (Substance Misuse in Adolescents in Residential Treatment)
RECRUITING · NA
-
Cultural Adaptation of Drug Treatment for DJJ Youth
RECRUITING · NA
-
Adaptation and Evaluation of Bright Horizons
RECRUITING · NA
-
Teen Health Choices & Wellness
RECRUITING · NA
-
Pre-exposure Prophylaxis (PrEP) Uptake and Adherence Intervention for Women with Trauma-related Conditions
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05566431 · 428 participants · NA
Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics
- NCT05646316 · 428 participants · Phase 3
Impact of Sentinel Lymph Node Mapping on Patient Reported Lower Extremity Limb Dysfunction in Stage I Endometrial Cancer
- NCT05797610 · 428 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Sefaxersen (RO7434656) in Participants With Primary Immunoglobulin A (IgA) Nephropathy at High Risk of Progression
- NCT06073626 · 428 participants · NA
Addressing Genomic Disparities in Cancer Survivors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI